<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We evaluated a role of <z:mp ids='MP_0005039'>hypoxia</z:mp>-inducible factor-1alpha (HIF-1alpha) and its downstream genes in <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo>-induced hemorrhagic transformation in a rat model of focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Male Sprague-Dawley rats weighing 280-300 g (n = 105) were divided into sham, 90 min middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO), MCAO plus HIF-1alpha inhibitors, 2-methoxyestradiol (2ME2) or 3-(5'-<z:chebi fb="0" ids="24712">hydroxymethyl</z:chebi>-2'-furyl)-1-benzylindazole (YC-1), groups </plain></SENT>
<SENT sid="2" pm="."><plain>Rats received an injection of 50% <z:chebi fb="10" ids="4167">dextrose</z:chebi> (6 ml/kg intraperitoneally) at 15 min before MCAO </plain></SENT>
<SENT sid="3" pm="."><plain>HIF-1alpha inhibitors were administered at the <z:hpo ids='HP_0003674'>onset</z:hpo> of reperfusion </plain></SENT>
<SENT sid="4" pm="."><plain>The animals were examined for neurological deficits and sacrificed at 6, 12, 24, and 72 hr following MCAO </plain></SENT>
<SENT sid="5" pm="."><plain>The cerebral tissues were collected for histology, zymography, and Western blot analysis </plain></SENT>
<SENT sid="6" pm="."><plain>The expression of HIF-1alpha was increased in ischemic brain tissues after MCAO and reduced by HIF-1alpha inhibitors </plain></SENT>
<SENT sid="7" pm="."><plain>In addition, 2ME2 reduced the expression of vascular endothelial growth factor (VEGF) and the elevation of active matrix metalloproteinase-2 and -9 (MMP-2/MMP-9) in the ipsilateral hemisphere </plain></SENT>
<SENT sid="8" pm="."><plain>Both 2ME2 and YC-1 reduced <z:mpath ids='MPATH_124'>infarct</z:mpath> volume and ameliorated neurological deficits </plain></SENT>
<SENT sid="9" pm="."><plain>However, only 2ME2 attenuated hemorrhagic transformation in the ischemic territory </plain></SENT>
<SENT sid="10" pm="."><plain>In conclusion, the inhibition of HIF-1alpha and its downstream genes attenuates hemorrhagic conversion of <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> and ameliorates neurological deficits after focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
</text></document>